The goal of this Roundtable is to understand and address the role of new and emerging LDL-C lowering therapies in patients with ASCVD and high-risk primary prevention as well as those with ...

Guideline on the Management of Blood Cholesterol, the 2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients with Persistent Hypertriglyceridemia, and the ...

Alzheimer's disease, a devastating neurodegenerative condition that impacts millions globally, may have found an unexpected ...

Zocor (simvastatin) and Lipitor (atorvastatin) are both statin drugs, which are medications used to lower cholesterol levels in the blood. Statins primarily work by inhibiting the enzyme HMG-CoA ...

However, in patients who require lipid-lowering ... non-HDL cholesterol is recommended as a secondary target for patients with elevated triglyceride levels. Statin-associated reductions in LDL ...

The trial evaluated the efficacy of obicetrapib, an oral, non-statin cholesterol-lowering medication, in patients with cardiovascular disease and high low-density lipoprotein cholesterol (LDL-C) ...

However, notable differences exist between European Society of Cardiology (ESC) and National Institute for Health and Care Excellence (NICE) guidelines on lipid lowering goals. For patients diagnosed ...

NEXLETOL is the first oral, once-daily, non-statin LDL-C lowering medicine approved since 2002 for indicated patients. NEXLETOL is a first-in-class ATP Citrate Lyase (ACL) inhibitor that lowers ...

In general, it's worth noting that off-label use of medications ... lowering statin. And in many cases, it's with good reason. For adults, we know that statins can help lower LDL cholesterol ...